Galle PR - Search Results

1

Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.

Fernholz D, Galle PR, Stemler M, Brunetto M, Bonino F, Will H. Fernholz D, et al. Among authors: galle pr. Virology. 1993 May;194(1):137-48. doi: 10.1006/viro.1993.1243. Virology. 1993. PMID: 8480417

2

Production of infectious duck hepatitis B virus in a human hepatoma cell line.

Galle PR, Schlicht HJ, Fischer M, Schaller H. Galle PR, et al. J Virol. 1988 May;62(5):1736-40. doi: 10.1128/JVI.62.5.1736-1740.1988. J Virol. 1988. PMID: 2833623 Free PMC article.

3

Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.

Bruss V, Hagelstein J, Gerhardt E, Galle PR. Bruss V, et al. Among authors: galle pr. Virology. 1996 Apr 15;218(2):396-9. doi: 10.1006/viro.1996.0209. Virology. 1996. PMID: 8610467 Free article.

4

pH-independent uptake of hepatitis B virus in primary human hepatocytes.

Hagelstein J, Fathinejad F, Stremmel W, Galle PR. Hagelstein J, et al. Among authors: galle pr. Virology. 1997 Mar 3;229(1):292-4. doi: 10.1006/viro.1996.8376. Virology. 1997. PMID: 9123873 Free article.

5

Proteaselike sequence in hepatitis B virus core antigen is not required for e antigen generation and may not be part of an aspartic acid-type protease.

Nassal M, Galle PR, Schaller H. Nassal M, et al. Among authors: galle pr. J Virol. 1989 Jun;63(6):2598-604. doi: 10.1128/JVI.63.6.2598-2604.1989. J Virol. 1989. PMID: 2657101 Free PMC article.

6

Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection.

Tavakoli S, Schwerin W, Rohwer A, Hoffmann S, Weyer S, Weth R, Meisel H, Diepolder H, Geissler M, Galle PR, Löhr HF, Böcher WO. Tavakoli S, et al. Among authors: galle pr. J Gen Virol. 2004 Oct;85(Pt 10):2829-2836. doi: 10.1099/vir.0.80143-0. J Gen Virol. 2004. PMID: 15448344

7

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.

Hempel G, Galle PR, Löhr HF. Hempel G, et al. Among authors: galle pr. J Med Virol. 2001 Jul;64(3):340-9. doi: 10.1002/jmv.1056. J Med Virol. 2001. PMID: 11424124

8

Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.

Pingel S, Weyer S, Galle PR, Löhr HF. Pingel S, et al. Among authors: galle pr. J Med Virol. 2002 Apr;66(4):472-80. doi: 10.1002/jmv.2168. J Med Virol. 2002. PMID: 11857524

9

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.

Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF. Dahmen A, et al. Among authors: galle pr. J Med Virol. 2002 Apr;66(4):452-60. doi: 10.1002/jmv.2165. J Med Virol. 2002. PMID: 11857521 Clinical Trial.

10

Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus infection by ELISA using a pre-S fusion protein expressed in E. coli.

Theilmann L, Burkhardt HD, Galle PR, Gmelin K, Kommerell B, Pfaff E. Theilmann L, et al. Among authors: galle pr. Arzneimittelforschung. 1988 Dec;38(12):1856-8. Arzneimittelforschung. 1988. PMID: 3072959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

842 results

Search Page

Filters